Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia
- PMID: 20889891
- PMCID: PMC2946768
- DOI: 10.4269/ajtmh.2010.10-0231
Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia
Abstract
A retrospective analysis was undertaken to determine the seroprevalence of Entamoeba histolytica infection in Sydney, Australia. Using an enzyme-linked immunosorbent assay, 429 high risk human immunodeficiency virus (HIV)-infected men who have sex with men (MSM), 446 low risk HIV-uninfected MSM, and 456 HIV-uninfected controls were assessed. Seroprevalence rates were 5.13% for the high risk HIV-infected MSM group, 0.22% for the low risk HIV-uninfected MSM group, and 0.44% for the control group. We found that high risk HIV-infected MSM have a significantly greater seroprevalence of E. histolytica with a relative risk of 22.87, when compared with low risk HIV-uninfected MSM and 11.69 when compared with controls. These findings show that in Sydney, sexually active HIV-infected MSM are at greater risk of developing amoebic disease caused by E. histolytica than HIV-uninfected MSM and the general population.
References
-
- Stauffer W, Radvin JI. Entamoeba histolytica: an update. Curr Opin Infect Dis. 2003;16:479–485. - PubMed
-
- Guerrant RL. Amebiasis: introduction, current status, and research questions. Rev Infect Dis. 1986;8:218–227. - PubMed
-
- Stanley SL. Amoebiasis. Lancet. 2003;361:1025–1034. - PubMed
-
- Haque R, Huston CD, Hughes M, Houpt E, Petri WA. Amebiasis. N Engl J Med. 2003;348:1565–1573. - PubMed
-
- Salit IE, Khairnar K, Gough K, Pillai DR. A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain. Clin Infect Dis. 2009;49:346–353. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
